BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34993460)

  • 1. Incidence and Predictors of Heart Failure in Patients With Atrial Fibrillation.
    Krisai P; Johnson LSB; Moschovitis G; Benz A; Ramasundarahettige C; McIntyre WF; Wong JA; Conen D; Sticherling C; Connolly SJ; Healey JS
    CJC Open; 2021 Dec; 3(12):1482-1489. PubMed ID: 34993460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LVS-HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World-Wide Registry.
    Johnson LSB; Oldgren J; Barrett TW; McNaughton CD; Wong JA; McIntyre WF; Freeman CL; Murphy L; Engström G; Ezekowitz M; Connolly SJ; Xu L; Nakamya J; Conen D; Bangdiwala SI; Yusuf S; Healey JS
    J Am Heart Assoc; 2021 Sep; 10(18):e017735. PubMed ID: 34514842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation.
    Inciardi RM; Giugliano RP; Claggett B; Gupta DK; Chandra A; Ruff CT; Antman EM; Mercuri MF; Grosso MA; Braunwald E; Solomon SD;
    Eur J Heart Fail; 2019 Dec; 21(12):1571-1579. PubMed ID: 31777160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term events following catheter-ablation for atrial fibrillation in heart failure with preserved ejection fraction.
    Ishiguchi H; Yoshiga Y; Shimizu A; Ueyama T; Fukuda M; Kato T; Fujii S; Hisaoka M; Uchida T; Omuro T; Okamura T; Kobayashi S; Yano M
    ESC Heart Fail; 2022 Oct; 9(5):3505-3518. PubMed ID: 35894764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure.
    Luo J; Xu S; Li H; Li Z; Liu B; Qin X; Gong M; Shi B; Wei Y
    ESC Heart Fail; 2020 Oct; 7(5):2762-2772. PubMed ID: 32578394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment for incident heart failure in individuals with atrial fibrillation.
    Schnabel RB; Rienstra M; Sullivan LM; Sun JX; Moser CB; Levy D; Pencina MJ; Fontes JD; Magnani JW; McManus DD; Lubitz SA; Tadros TM; Wang TJ; Ellinor PT; Vasan RS; Benjamin EJ
    Eur J Heart Fail; 2013 Aug; 15(8):843-9. PubMed ID: 23594831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation.
    Weber C; Hung J; Hickling S; Nedkoff L; Murray K; Li I; Briffa TG
    Heart; 2021 Aug; 107(16):1320-1326. PubMed ID: 33707226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.
    De Filippo O; D'Ascenzo F; Wańha W; Leonardi S; Raposeiras Roubin S; Fabris E; Truffa Giachet A; Huczek Z; Gaibazzi N; Ielasi A; Cortese B; Borin A; Núñez-Gil IJ; Ugo F; Marengo G; Bianco M; Barbieri L; Marchini F; Desperak P; Melendo-Viu M; Montalto C; Bruno F; Mancone M; Ferrandez-Escarabajal M; Morici N; Scaglione M; Tuttolomondo D; Gąsior M; Mazurek M; Gallone G; Campo G; Wojakowski W; Abu Assi E; Sinagra G; de Ferrari GM
    Int J Cardiol; 2023 Jan; 370():35-42. PubMed ID: 36306949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study.
    Dong Z; Du X; Lu S; Jiang C; Xia S; He L; Su X; Jia Z; Long D; Sang C; Tang R; Liu N; Bai R; Yu R; Dong J; Ma C
    BMC Cardiovasc Disord; 2021 Mar; 21(1):146. PubMed ID: 33740910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
    Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent heart failure hospitalizations increase the risk of mortality in heart failure patients with atrial fibrillation and type 2 diabetes mellitus in the United Kingdom: a retrospective analysis of Clinical Practice Research Datalink database.
    Lahoz R; Fagan A; McSharry M; Proudfoot C; Corda S; Studer R
    BMC Cardiovasc Disord; 2022 May; 22(1):234. PubMed ID: 35597922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design.
    Parkash R; Wells G; Rouleau J; Talajic M; Essebag V; Skanes A; Wilton SB; Verma A; Healey JS; Tang AS
    Am Heart J; 2021 Apr; 234():90-100. PubMed ID: 33472052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and predictors of one-year outcome of heart failure patients with atrial fibrillation compared to heart failure patients in sinus rhythm.
    Ozierański K; Kapłon-Cieślicka A; Peller M; Tymińska A; Balsam P; Galas M; Marchel M; Crespo-Leiro M; Maggioni AP; Drożdż J; Opolski G
    Kardiol Pol; 2016; 74(3):251-61. PubMed ID: 26365943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
    J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Eligibility for a Sodium-Glucose Cotransporter 2 Inhibitor and Cardiovascular Events in Patients With Atrial Fibrillation.
    Oraii A; Healey JS; Benz AP; Pandey AK; Wong JA; Fonguh S; Wang J; Conen D; Gerstein HC; Connolly SJ; McIntyre WF
    Can J Cardiol; 2022 Sep; 38(9):1434-1441. PubMed ID: 35562018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.